Financials

  • Market Capitalization 28.95 M
  • Employee 70
  • Founded 2005
  • CEO N/A
  • Website www.igcinc.us
  • Headquarter Maryland, United States
  • FIGI BBG000NSSLY8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.02
Fiyat/satışlar oranı
22.79

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4431
QNCX
Quince Therapeutics, Inc. - Common Stock
29.55 USD+2.04%-7.31%-5.71%+1746.88%30.05 M USD
4442
ESLA
Estrella Immunopharma, Inc. - Common Stock
0.67 USD0.00%+4.69%-6.94%-38.53%29.14 M USD
4448
RNAZ
TransCode Therapeutics, Inc. - Common Stock
1.69 USD0.00%-14.65%-51.58%-82.23%28.61 M USD
4464
CVM
Cel-Sci Corporation Common Stock
1.50 USD-1.32%-10.18%+0.67%-70.87%26.38 M USD

Haberler